Bioinformatics in cancer: Unveiling molecular pathways and diagnostic targets

In the field of cancer research, bioinformatics plays a pivotal role in dissecting the intricate molecular interactions that dictate cancer development and progression. Despite significant advances in our understanding of cancer genetics and biology, many questions remain unanswered regarding genome organization, mutation impacts, and epigenetic influences on tumor growth. Recent studies highlight the potential of bioinformatics in elucidating stress response mechanisms, cell signaling pathways, and alterations in molecular expression—both RNA and protein—that collectively contribute to the malignancy of cancers. However, the ongoing challenge is to effectively integrate diverse bioinformatic approaches to extract actionable insights that can lead to novel therapeutic targets and better diagnostic markers.

This Research Topic aims to employ cutting-edge bioinformatics analyses to deepen our understanding of the molecular basis of cancer. Through integrating computational models and algorithms, the goal is to uncover new genetic, epigenetic, and proteomic insights into cancer mechanisms and identify potential predictive biomarkers for therapy response and prognosis. Identifying novel molecular targets for therapy will not only advance basic cancer research but also offer avenues for more precise and effective clinical interventions.

To gather further insights in this intersection of bioinformatics and oncology, we welcome articles addressing, but not limited to, the following themes:

- Application of bioinformatics algorithms to dissect cancer genome architecture and mutation profiling

- Exploration of epigenetic modifications and their role in tumorigenesis

- Identification of novel stress response and cell signaling pathways in cancer progression

- Innovations in RNA and protein expression analysis for cancer diagnosis

- Development of bioinformatics-based predictive models for therapeutic response and survival outcomes

We invite submissions that utilize novel computational approaches, integrate multi-omics data, and offer new insights into cancer biology and treatment.